News Overview

Quant Biomarkers AG


Quant Biomarkers’ primary mission is to advance biomarker technologies, detect and predict early signs of chronic diseases for individualized interventions in longevity medicine. We target the biology and root cause of aging as our foundation for disease prevention and development of regenerative medicines. At the intersection of medical science and digital technology we augment access to early, optimized, effective care decisions to improve health outcomes and reduce costs. We pioneer the use of virtual tissue technology for aging related diseases focused on personalised biomarker panels and new targeted interventions to prevent or delay the onset of chronic diseases.Our focus is on developing proprietary, personalised, biomarker panels, predictive tools and methods for health and disease trajectories combining longitudinal medical data analysis with molecular cell and tissue level simulations.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.